What's new
about our new
vegetarian capsules? 

Everything.

LEARN MORE

Scroll down

We’ve been supplying our customers with vegetarian capsules for many years.

But if you ask us what’s new about these ones, the short answer is: EVERYTHING.

They’re cleaner

Completely natural and free from animal products; with an independent ‘clean label’ certification - a world first. They contain no artificial colourants, are completely free of titanium dioxide, and are perfect for dietary supplements and other nutraceutical products.

They’re more targeted

We have a range of variants for different applications – from time-dependent and delayed release capsules that protect acid-sensitive drugs from gastric fluids, to others that cater for more complex and sensitive formulations. We can even collaborate on creating a purpose-made solution for your specific delivery needs.  

They can be customised

Our capsules are perfectly clear to show off your product, but you can also choose to colour them, and print on them (all completely naturally, of course) for additional brand appeal.

So, while our new vegetarian capsules aren’t the first we’ve ever made, they certainly are the best. Contact us to find out more. 

CLICK HERE

Go to article: Home | Catching the next Covid-19 variantGo to article: In this issueGo to article: ContentsGo to article: HOF Sonderanlagenbau Company Insight Go to article: HOF SonderanlagenbauGo to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: Mimotopes Company Insight Go to article: MimotopesGo to article: Mettler Toledo Company InsightGo to article: Data Integrity Solutions – METTLER TOLEDOGo to article: CommentGo to article: New coronavirus variant causing concern as cases spike in South AfricaGo to article: Teva and MedinCell looking to enter LAI schizophrenia marketGo to article: Lack of injectable anti-HIV therapies in the Japanese marketGo to article: Prevention of thrombosis in Covid-19 patientsGo to article: T2D therapy accepted into FDA Emerging Technology ProgramGo to article: Owen Mumford Company Insight Go to article: Owen MumfordGo to article: ButterworthGo to article:  Molnár-Institute Company Insight Go to article: Molnar-InstituteGo to article: In DepthGo to article: Enter Amazon Pharmacy: the beginning of a great online pharmacy fight?Go to article: Covid-19 vaccines have made treating racism in medicine even more urgentGo to article: Could Covid-19 give pharma the chance for the ultimate image makeover?Go to article: Delivering a billion doses with the UK VMICGo to article: Tackling the ‘silent pandemic’ of AMR: WHO launches the Global Leaders GroupGo to article: Saxenda: profiling the first NHS weight loss drug for a decadeGo to article: How real-time genomic surveillance could spot new Covid-19 variantsGo to article: A new hope for slowing disability in MSGo to article: DatwylerGo to article: Datwyler Company Insight Go to article: ACG WorldwideGo to article: Gemini Data LoggersGo to article: In DataGo to article: Inside the dealGo to article: Deals analysisGo to article: The pharma industry key listGo to article: Global markets and indicesGo to article:  Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: EventsGo to article: Next issue